These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6139797)

  • 21. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jul; 20(1):1-23. PubMed ID: 6105067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choice of antihypertensive medications among physicians and its impact on blood pressure control among Nigerians living with hypertension.
    Mijinyawa Muhammad S; Yusuf MS; Mohammed H; Saidu H; Sulaiman BA; Uloko AE
    Niger J Med; 2016; 25(3):220-5. PubMed ID: 30011166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Celiprolol efficacy and tolerance in the treatment of arterial hypertension].
    Lobos Bejarano JM; Granados Menéndez MI; del Valle González J; Bravo Juega P
    An Med Interna; 1991 Jan; 8(1):52-3. PubMed ID: 1680475
    [No Abstract]   [Full Text] [Related]  

  • 26. [Alpha beta-blockers for patients with hypertension].
    Mizuta Y; Imaizumi T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():305-9. PubMed ID: 16981560
    [No Abstract]   [Full Text] [Related]  

  • 27. Nadolol (corgard) in severe and resistant hypertension.
    Nontak MA
    Med J Malaysia; 1981 Sep; 36(3):181-5. PubMed ID: 6120443
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta-Blockers in the Treatment of Hypertension in the 90's: Experience with Tertatolol. Conference proceedings. Istanbul, Turkey, October 19, 1993.
    Cardiology; 1993; 83 Suppl 1():1-72. PubMed ID: 7903209
    [No Abstract]   [Full Text] [Related]  

  • 29. [The new beta blocker Betapressin. Long-term experience in hypertensive patients in ambulatory care].
    Dameris W
    ZFA (Stuttgart); 1981 Mar; 57(8):628-32. PubMed ID: 6111871
    [No Abstract]   [Full Text] [Related]  

  • 30. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic.
    Salmasi AM; Alimo A; Dancy M
    Am J Hypertens; 2004 Jun; 17(6):483-8. PubMed ID: 15177519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial experience with a new long-acting beta-blocker, nadolol, in hypertensive patients.
    Hitzenberger G
    J Int Med Res; 1979; 7(1):33-8. PubMed ID: 33862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
    [No Abstract]   [Full Text] [Related]  

  • 34. Methyldopa (Aldomet) in combination with timolol (Blocadren) in the treatment of hypertension.
    Seedat YK
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):10-8. PubMed ID: 8279
    [No Abstract]   [Full Text] [Related]  

  • 35. Prorenin and beta-blockade in hypertension.
    McKenna F; Davison AM
    Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta-adrenoblockers for the correction of arterial hypertension in postmenopausal women].
    Latfullin IA; Ishmurzin GP; Gaĭfullina RF; Akhmerova RI; Kim ZF; Podol'skaia AA
    Klin Med (Mosk); 2010; 88(2):68-71. PubMed ID: 21105477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of the hypotensive effects of nadolol].
    Hanzlik J; Sodolski W; Stelmasiak T; Wolański I
    Kardiol Pol; 1982; 25(2):101-6. PubMed ID: 6125620
    [No Abstract]   [Full Text] [Related]  

  • 38. Nadolol: a new beta-adrenoceptor antagonist.
    Frishman WH
    N Engl J Med; 1981 Sep; 305(12):678-82. PubMed ID: 6115316
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ambulatory treatment of hypertension with the beta-blockader corgard (nadolol)].
    Charyev KhE; Erina EV; Iurenev AP; Lediasheva GA
    Ter Arkh; 1984; 56(11):43-6. PubMed ID: 6523386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.